PHARPharming Group N.V.
Is it safe?
Big price swings. That is the only one of 6 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Large price swings, high volatility. Worst drawdown -60% · now 54% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can PHAR take a bad year?
The deepest fall in PHAR's price history on file is −60%; it is 54% below its high today.
Worst drawdown on file · −54% today
- Interest cover
- 132×
Interest cover · operating profit covers the interest bill several times over
- Annualised volatility
- 66%
Annualised volatility · three times the market's own swing
Details›
- Cash and short-term investments
- $145M
- EBITDA, trailing twelve months
- $27M
- Operating profit, trailing twelve months
- $26M
- Annualised volatilitytwo years of daily moves
- 66%
- Worst drawdown on file
- −60%
- Below its 52-week high
- 54%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.